2028年までの中南米血尿治療市場予測 - 新型コロナウイルス感染症(COVID-19)の影響と治療法(薬剤、治療法、その他)、適応症(尿路感染症、腎臓結石、尿道炎、血液がん、膀胱結石、前立腺がん、膀胱炎)別の地域分析、外傷、激しい運動、多発性嚢胞腎、子宮内膜症、月経)、タイプ(肉眼的血尿、顕微鏡的血尿、特発性血尿、ジョガー血尿)、エンドユーザー(病院、診療所、外来手術センターなど)

TIPRE00026253 | Pages: 164 | Pharmaceuticals | Dec 2021 | Type: Regional | Status: Published

市場紹介

血尿は、尿中に血液が認められる病状です。 。一般に、尿には赤血球が含まれていないため、腎臓結石、尿路感染症、その他の遺伝性疾患を引き起こす可能性のある深刻な問題が発生する可能性があります。

さらに、血尿の有病率が高いため、関連する兆候は、予測期間中に市場の成長を促進すると予想されます。しかし、関連する兆候の未診断の症例は、南部および地域の成長を制限しています。中米の血尿治療市場。

SARS-CoV-2 のパンデミックは、SCAM 地域の医療に突然、劇的な影響を与えました。新型コロナウイルス感染症のパンデミックにより、病院管理において受け入れられている選択的症例の日常的な治療が変化しました。中南米も例外ではありません。現在は厳格な社会的距離措置が適用されており、患者は付き添いなしで個別にクリニックに入院することになっている。 CoViD-19 はほぼ世界中で日常生活を変えました。全体として、この混乱の大きさは、パンデミックの地域的な影響に対する個人の恐怖と政府レベルの行動によるものです。ただし、問題の急速な進展が不明な初期段階では、地域社会の健康を確保するために制限措置が講じられる場合があります。アルゼンチンでは、これが計画された医療を麻痺させる状況でした。このような制限は研究開発活動に悪影響を与える可能性があり、この地域の血尿治療市場の成長を直接的に抑制することになります。

市場の概要とダイナミクス

南部と地域中米の血尿治療市場は、2021年の5,780万米ドルから2028年までに6,570万米ドルに達すると予測されています。 2021 年から 2028 年まで CAGR 1.8% で成長すると予想されています。医療機器や診断手順の技術開発により、腎臓結石、膀胱結石、尿路感染症などの血尿に関連する適応症を管理するためのさまざまな選択肢が生まれました。先進的な治療技術の利用により、患者ケアの向上が期待されています。たとえば、尿路結石症の治療のための手術におけるロボット工学の導入は、近年人気を集めています。現在、Intuitive Surgical Inc. の Vinci Surgical System は、尿路結石症の治療手術に広く使用されています。同様に、腎臓結石に対する内科学的介入の受け入れは、さまざまな国で大幅に増加しています。また、関連する適応症の進歩が南部および米国の治療を支援する可能性が高いと予想されます。予測期間中の中米血尿治療市場。

主要市場セグメント

<種類別に見ると、肉眼的血尿セグメントが南部と日本で最大のシェアを占めました。 2020年の中米血尿治療市場。治療に関しては、医薬品セグメントが南部および中米で最大のシェアを占めた。 2020年の中米血尿治療市場。適応症に関しては、尿路感染症セグメントが南部および中米で最大のシェアを占めた。 2020年の中米血尿治療市場。エンドユーザーに関しては、病院セグメントが南部および中米で最大のシェアを占めた。 2020 年の中米血尿治療市場。

主要な供給源と企業のリスト

< p>南部および米国の血尿治療市場に関するこのレポートを作成するために参照したいくつかの主要な一次および二次情報源。中米には、企業の Web サイト、年次報告書、財務報告書、国家政府の文書、統計データベースなどが含まれます。報告書に記載されている主要企業は、アストラゼネカ、ブリストル・マイヤーズ スクイブ社、F. ホフマン・ラ・ロッシュ社、グラクソ・スミスクライン社、ヤンセン・ファーマシューティカルズ社、メルク・アンド・ヘルスケア社などです。 Co., Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd、および Boehringer Ingelheim International GmbH。

レポートを購入する理由

  • 南部と南部を理解するため。中米の血尿治療市場の状況を把握し、高い収益を保証できる市場セグメントを特定する
  • 絶えず変化する市場の状況を理解し、競争で優位に立つため
  • 南部および南部における合併と買収、およびパートナーシップ取引を効率的に計画するため。最も売上が見込めるセグメントを特定することにより、中米の血尿治療市場において
  • さまざまなセグメントの市場パフォーマンスを鋭敏かつ包括的に分析し、知識に基づいたビジネス上の意思決定を行う
  • 南部および南部の市場収益予測を取得します。 2021 年から 2028 年のさまざまなセグメントに基づく中米の血尿治療市場

南米および南米中米血尿治療市場セグメンテーション

< span>治療

  • 療法
  • その他

適応症別

  • 尿路感染症
  • 腎臓結石
  • 尿道炎
  • 血液がん
  • 膀胱結石
  • 前立腺がん
  • 膀胱炎
  • 外傷
  • 激しい運動
  • < scan>多発性嚢胞腎
  • 子宮内膜症
  • 月経

タイプ別

  • 肉眼的血尿
  • 顕微鏡的血尿
  • 特発性血尿
  • ジョガー血尿

エンド ユーザー別

  • 病院
  • クリニック
  • 外来手術センター (ASC)
  • その他

国別

  • 南部と南部。中央アメリカ
    • ブラジル
    • アルゼンチン
    • その他の南部およびその他の地域中央アメリカ

記載されている企業

  • アストラゼネカ
  • ブリストル・マイヤーズ スクイブ社
  • F.ホフマン・ラ・ロッシュ株式会社
  • グラクソ・スミスクライン plc.
  • ヤンセン・ファーマシューティカルズ
  • メルク&メルク社株式会社
  • ノバルティス AG
  • ファイザー株式会社
  • < span>サンファーマシューティカルインダストリーズ株式会社
  • ベーリンガーインゲルハイムインターナショナルGmbH

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Hematuria Treatment Market – By Treatment

1.3.2        South & Central America Hematuria Treatment Market – By Indication

1.3.3        South & Central America Hematuria Treatment Market – By Type

1.3.4        South & Central America Hematuria Treatment Market – By End User

1.3.5        South & Central America Hematuria Treatment Market – By Country

2.           South & Central America Hematuria Treatment Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Hematuria Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America – PEST Analysis

4.3         Experts Opinion

5.           Hematuria Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Prevalence of Hematuria-Associated Indications

5.1.2        Increasing Awareness About Treatment Options and Improving Healthcare Expenditure

5.2         Market Restraints

5.2.1        Undiagnosed Cases of Associated Indications

5.3         Market Opportunities

5.3.1        Increasing Opportunities for Related Treatments

5.4         Future Trends

5.4.1        Rise in Preference for Advanced Therapies

5.5         Impact Analysis

6.           Hematuria Treatment Market – South & Central America Analysis

6.1         South & Central America Hematuria Treatment Market Revenue Forecast and Analysis

7.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment

7.1         Overview

7.2         South & Central America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

7.3         Drugs

7.3.1        Overview

7.3.2        Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Therapies

7.4.1        Overview

7.4.2        Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Others

7.5.1        Overview

7.5.2        Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication

8.1         Overview

8.2         South & Central America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

8.3         Kidney Stones

8.3.1        Overview

8.3.2        Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Urinary Tract Infections (UTI)

8.4.1        Overview

8.4.2        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Urethritis

8.5.1        Overview

8.5.2        Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Blood Cancer

8.6.1        Overview

8.6.2        Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Bladder Stones

8.7.1        Overview

8.7.2        Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Prostate Cancer

8.8.1        Overview

8.8.2        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.9         Cystitis

8.9.1        Overview

8.9.2        Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.10      Trauma

8.10.1     Overview

8.10.2     Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.11      Vigorous Exercise

8.11.1     Overview

8.11.2     Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.12      Polycystic Kidney Disease

8.12.1     Overview

8.12.2     Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.13      Endometriosis

8.13.1     Overview

8.13.2     Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.14      Menstruation

8.14.1     Overview

8.14.2     Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

9.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Type

9.1         Overview

9.2         South & Central America Hematuria Treatment Market, By Type 2020 & 2028 (%)

9.3         Macroscopic Hematuria

9.3.1        Overview

9.3.2        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.4         Microscopic Hematuria

9.4.1        Overview

9.4.2        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.5         Idiopathic Hematuria

9.5.1        Overview

9.5.2        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.6         Jogger’s Hematuria

9.6.1        Overview

9.6.2        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

10.        Hematuria Treatment Market Revenue and Forecast To 2028 – By End User

10.1      Overview

10.2      South & Central America Hematuria Treatment Market Share by End User 2020 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Clinics

10.4.1     Overview

10.4.2     Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.5      Ambulatory Surgical Centers (ASC’s)

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.6      Others

10.6.1     Overview

10.6.2     Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

11.        South & Central America Hematuria Treatment Market – Geographic Analysis

11.1      South and Central America: Hematuria Treatment Market

11.1.1     Overview

11.1.2     South and Central America: Hematuria Treatment Market - Revenue and Forecast to 2028 (USD Million)

11.1.3     South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.4     South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)

11.1.5     South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)

11.1.6     South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.1.7     South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)

11.1.7.1       Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

11.1.7.1.1       Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

11.1.7.1.2       Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.3       Brazil: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)

11.1.7.1.4       Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.5       Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.2       Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

11.1.7.2.1       Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

11.1.7.2.2       Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.3       Argentina: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)

11.1.7.2.4       Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.5       Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.3       Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

11.1.7.3.1       Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

11.1.7.3.2       Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.3       Rest of South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)

11.1.7.3.4       Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.5       Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on Hematuria Treatment Market

12.1      South & Central America: Impact Assessment of COVID-19 Pandemic

13.        Hematuria Treatment Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies Done by the Companies in the Market, (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      AstraZeneca

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bristol-Myers Squibb Company

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      F. HOFFMANN-LA ROCHE LTD.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      GlaxoSmithKline Plc

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Janssen Pharmaceuticals

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Merck & Co., Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Novartis AG

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Pfizer Inc.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Sun Pharmaceutical Industries Ltd

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Boehringer Ingelheim International GmbH

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)

Table 2.             South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 3.             South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million

Table 4.             South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Thousand)

Table 5.             Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)

Table 6.             Brazil Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)

Table 10.          Argentina Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Organic Developments Done by Companies

Table 18.          Inorganic Developments Done by Companies

Table 19.          Glossary of Terms, Hematuria Treatment Market

 


LIST OF FIGURES

Figure 1.           Hematuria Treatment Market Segmentation

Figure 2.           South & Central America Hematuria Treatment Market Overview

Figure 3.           Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market

Figure 4.           Brazil to Show Significant Growth During Forecast Period

Figure 5.           South & Central America Hematuria Treatment Market, Industry Landscape

Figure 6.           South & Central America PEST Analysis

Figure 7.           Hematuria Treatment Market Impact Analysis of Drivers and Restraints

Figure 8.           South & Central America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           South & Central America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

Figure 10.        Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 11.        Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 12.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 13.        South & Central America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

Figure 14.        Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 15.        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 16.        Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 17.        Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 18.        Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 19.        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 20.        Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 21.        Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 22.        Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 23.        Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 24.        Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 25.        Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 26.        South & Central America Hematuria Treatment Market, by Type 2020 & 2028 (%)

Figure 27.        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 28.        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 29.        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 30.        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 31.        South & Central America Hematuria Treatment Market Share by End User 2020 & 2028 (%)

Figure 32.        Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 33.        Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 34.        Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 35.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 36.        South and Central America: Hematuria Treatment Market, By Key Country – Revenue (2021) (USD Million)

Figure 37.        South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

Figure 38.        South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)

Figure 39.        Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

Figure 40.        Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

Figure 41.        Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)

Figure 42.        Impact Of COVID-19 Pandemic in South & Central America Country Markets

Figure 43.        Growth Strategies Done by the Companies in the Market, (%)

  1. AstraZeneca
  2. Bristol-Myers Squibb Company
  3. F. HOFFMANN-LA ROCHE LTD.
  4. GlaxoSmithKline plc.
  5. Janssen Pharmaceuticals
  6. Merck & Co., Inc.
  7. Novartis AG
  8. Pfizer Inc.
  9. Sun Pharmaceutical Industries Ltd
  10. Boehringer Ingelheim International GmbH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America hematuria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000